Skip to main content
. 2024 Mar 5;25:25. doi: 10.1186/s40360-024-00746-6

Fig. 1.

Fig. 1

Initial evaluation of standard anticancer drugs. (a) The 384-well plate-based tumor-immune model system with mono- and co-cultures analyzed using an image-based readout. (b-c) The viability (expressed as % of control) in HCT116-GFP (b) and A549-NLR (c) monocultures and cancer-immune co-cultures after treatment with the drug panel at 1 µM and 10 µM for 72 h (data shown as means from three technical replicates). (d-e) Bliss scores calculated at 1 µM and 10 µM for the 16 drugs that were selected for validation experiments